The unfavorable effects of COVID ‐19 on Dutch advanced melanoma care

Author:

Not Olivier J.12ORCID,Breeschoten Jesper13ORCID,Eertwegh Alfonsus J. M.3,Hilarius Doranne L.4,De Meza Melissa M.156,Haanen John B.7,Blank Christian U.78,Aarts Maureen J. B.9,Berkmortel Franchette W. P. J.10,Groot Jan Willem B.11,Hospers Geke A. P.12,Ismail Rawa K.113ORCID,Kapiteijn Ellen14,Piersma Djura15,Rijn Rozemarijn S.16,Stevense‐den Boer Marion A. M.17,Veldt Astrid A. M.18,Vreugdenhil Gerard19,Boers‐Sonderen Marye J.20,Blokx Willeke A. M.21,Suijkerbuijk Karijn P. M.2,Wouters Michel W. J. M.156

Affiliation:

1. Scientific Bureau Dutch Institute for Clinical Auditing Leiden The Netherlands

2. Department of Medical Oncology University Medical Center Utrecht Utrecht The Netherlands

3. Department of Medical Oncology, Amsterdam UMC VU University Medical Center, Cancer Center Amsterdam Amsterdam The Netherlands

4. Department of Pharmacy Rode Kruis Ziekenhuis Beverwijk The Netherlands

5. Department of Biomedical Data Sciences Leiden University Medical Center Leiden The Netherlands

6. Department of Surgical Oncology Netherlands Cancer Institute Amsterdam The Netherlands

7. Department of Medical Oncology and Immunology Netherlands Cancer Institute Amsterdam The Netherlands

8. Division of Molecular Oncology and Immunology Netherlands Cancer Institute Amsterdam The Netherlands

9. Department of Medical Oncology GROW School of Developmental Biology, Maastricht University Medical Center Maastricht The Netherlands

10. Department of Medical Oncology Zuyderland Medical Center Sittard Sittard‐Geleen The Netherlands

11. Department of Medical Oncology Isala Oncology Center Isala The Netherlands

12. Department of Medical Oncology, University Medical Center Groningen University of Groningen Groningen The Netherlands

13. Division of Pharmacoepidemiology and Clinical Pharmacology Utrecht Institute for Pharmaceutical Sciences Utrecht The Netherlands

14. Department of Medical Oncology Leiden University Medical Center Leiden The Netherlands

15. Department of Internal Medicine Medisch Spectrum Twente Enschede The Netherlands

16. Department of Internal Medicine Medical Center Leeuwarden Leeuwarden The Netherlands

17. Department of Internal Medicine Amphia Hospital Breda The Netherlands

18. Department of Medical Oncology and Radiology & Nuclear Medicine Erasmus Medical Center Rotterdam The Netherlands

19. Department of Internal Medicine Maxima Medical Center Eindhoven The Netherlands

20. Department of Medical Oncology Radboud University Medical Center Nijmegen The Netherlands

21. Department of Pathology University Medical Center Utrecht Utrecht The Netherlands

Funder

ZonMw

Bristol-Myers Squibb

Les Laboratories Pierre Fabre

Merck Sharp and Dohme

Novartis Pharma

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3